Working… Menu
Trial record 23 of 318 for:    colon cancer | ( Map: Canada )

A Phase I/II Study of IXO With Bevacizumab in Patients With Metastatic Colorectal Cancer (IXO+A)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00819754
Recruitment Status : Terminated
First Posted : January 9, 2009
Last Update Posted : January 14, 2014
Hoffmann-La Roche
Ottawa Regional Cancer Foundation
Information provided by (Responsible Party):
Ottawa Hospital Research Institute

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : February 2012
Actual Study Completion Date : May 2012